welcome
The Motley Fool

The Motley Fool

Health

Health

Why Shares of Axsome Therapeutics Slumped Today

The Motley Fool
Summary
Nutrition label

72% Informative

Shares of Axsome Therapeutics (NASDAQ: AXSM ) had declined 6% at 11 a.m. ET today .

The slump comes after the company announced the results of a phase 3 trial of solriamfetol (brand name Sunosi ) in major depressive disorder ( MDD ) The trial was a six-week proof-of-concept trial for MDD "with and without severe excess daytime sleepiness ( EDS ) Still, there's data to indicate a positive response in severe EDS cases.

VR Score

62

Informative language

56

Neutral language

14

Article tone

formal

Language

English

Language complexity

48

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.